Bictegravir/emtricitabine/tenofovir alafenamide
Bictegravir/emtricitabine/tenofovir alafenamide (pronunciation: bik-TEG-ra-vir/em-tri-SYE-ta-been/te-NOE-fo-vir al-a-FEN-a-mide) is a fixed-dose combination of antiretroviral medications used in the treatment of HIV/AIDS.
Etymology
The name "Bictegravir/emtricitabine/tenofovir alafenamide" is derived from the names of the three active ingredients it contains: Bictegravir, Emtricitabine, and Tenofovir alafenamide.
Usage
Bictegravir/emtricitabine/tenofovir alafenamide is used to treat HIV, the virus that can cause AIDS. It is not a cure for HIV or AIDS, but it can keep HIV under control and reduce the impact of the disease on the patient's life.
Components
The medication consists of three different drugs:
- Bictegravir is an integrase inhibitor that prevents the virus from integrating into the genetic material of human cells.
- Emtricitabine is a nucleoside reverse transcriptase inhibitor (NRTI) that prevents the virus from replicating in the body.
- Tenofovir alafenamide is also an NRTI that works in a similar way to emtricitabine.
Side Effects
Like all medicines, Bictegravir/emtricitabine/tenofovir alafenamide can cause side effects, although not everybody gets them. Some common side effects include nausea, diarrhea, and headache.
See Also
External links
- Medical encyclopedia article on Bictegravir/emtricitabine/tenofovir alafenamide
- Wikipedia's article - Bictegravir/emtricitabine/tenofovir alafenamide
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski